Ritual use of ayahuasca within the context of the Brazilian ayahuasca churches often starts during late childhood or early adolescence. Premature access to psychoactive drugs may represent a risk factor for drug misuse. Conversely, religious affiliation seems to play a protective role in terms of substance abuse. The objective of this study was to describe patterns of drug use in a sample of adolescents using ayahuasca within a religious setting. Forty-one adolescents from a Brazilian ayahuasca sect were compared with 43 adolescents who never drank ayahuasca. No significant differences were identified in terms of lifetime substance consumption. Throughout the previous year period, ayahuasca adolescents used less alcohol (46.31%) than the comparison group (74.4%). Recent use of alcohol was also more frequent among the latter group (65.1%) than among ayahuasca drinkers (32.5%). Although not statistically significant, slight differences in terms of patterns of drug use were definitely observed among groups. Despite their early exposure to a hallucinogenic substance, adolescents using ayahuasca in a controlled setting were mostly comparable to controls except for a considerably smaller proportion of alcohol users. Religious affiliation may have played a central role as a possible protective factor for alcohol use. Thus, ayahuasca seems to be a relatively safe substance as far as drug misuse is concerned.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/02791072.2005.10399794 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers.
J Psychopharmacol
October 2024
Department of Medicine, Diabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Article Synopsis
- Harmine, a key ingredient in the hallucinogenic drink Ayahuasca, raises questions about its psychoactive effects, maximum tolerated dose (MTD), and safety in humans when administered in pharmaceutical-grade form.
- A Phase 1 trial with 25 healthy adults tested varying doses of harmine hydrochloride (100-500 mg) to assess safety and potential psychoactivity, identifying the MTD as between 100 and 200 mg while noting mild to moderate gastrointestinal and neurological side effects.
- Results indicate that doses below 2.7 mg/kg of harmine HCl are generally safe with few adverse effects, while higher doses lead to more severe reactions and limited psychoactivity, marking this
Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial.
J Clin Psychopharmacol
June 2024
Department of Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Background: Ayahuasca is a South American plant hallucinogen rich in the psychedelic N,N-dimethyltryptamine and β-carbolines (mainly harmine). Preclinical and observational studies suggest that ayahuasca exerts beneficial effects in substance use disorders, but these potentials were never assessed in a clinical trial.
Methods: Single-center, single-blind, feasibility, proof-of-concept study, assessing the effects of one dose of ayahuasca accompanied by psychological support (without psychotherapy) on the drinking patterns (primary variable) of 11 college students with harmful alcohol consumption.
The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.
Clin Toxicol (Phila)
April 2024
New South Wales Poison's Information Centre, Sydney Children's Hospitals Network, Westmead, Sydney, Australia.
Article Synopsis
- Recent years have seen a rise in the use of classical psychedelics in Australia, but there’s limited knowledge about their toxicity levels.
- A study analyzed calls to the New South Wales Poisons Information Centre from 2014 to 2022 regarding psychedelic exposures, revealing a total of 737 calls primarily concerning LSD and psilocybin.
- Findings indicated a significant increase in calls over the years, with most cases involving young adult males and common symptoms including hallucinations and gastrointestinal issues; many calls involved co-ingestion with other substances.
Psychedelic Drug Legislative Reform and Legalization in the US.
JAMA Psychiatry
January 2023
Department of Psychiatry, Washington University in St Louis, St Louis, Missouri.
Importance: Psychedelic drugs are becoming accessible in the US through a patchwork of state legislative reforms. This shift necessitates consensus on treatment models, education and guidance for health care professionals, and planning for implementation and regulation.
Objective: To assess trends in psychedelics legislative reform and legalization in the US to provide guidance to health care professionals, policy makers, and the public.
Adaptation and latent structure of the Brazilian version of the Ego Dissolution Inventory (EDI-BR): an exploratory study.
Trends Psychiatry Psychother
June 2024
Departamento de Psicologia, Pontifícia Universidade Católica do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Objective: Existing scales that seek to measure alterations in self-experience were developed based on studies conducted in developed countries. Therefore, the aim of this study was to evaluate the psychometric properties of the Ego Dissolution Inventory (EDI) after translating and adapting it for the Brazilian context.
Methods: The measure was translated by two translators fluent in both English and Portuguese, followed by back-translation into English to ensure there was no loss of meaning.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!